Treatment with AgoPAMs caused a significant and sustained increase in glucagon, while MK-8666 only showed a trend of increasing glucagon on day 28 ( Fig 5B ).
← all excerpts
GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodent.
1
—
—